Cc1n[nH]c(O)c1C(c1ccc(N(C)C)c(Br)c1)c1c(C)n[nH]c1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?